Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy

Journal:

Cancer Cell

Published:

2025-07-14

DOI:

10.1016/j.ccell.2025.05.006

Affiliations:

7

Authors:

12

Go to article

Institutions	Authors	Share
University of Pennsylvania Health System (UPHS), United States of America (USA)	6.833333	0.57
Myrio Therapeutics Pty, Ltd., Australia	4.000000	0.33
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.666667	0.06
University of Pennsylvania (Penn), United States of America (USA)	0.500000	0.04

Interested in Oncology and Carcinogenesis?